Evidence map›Paper›PMID 40636280›Full record

ArticleMediterranean journal of hematology and infectious diseases2025

Efficacy and Safety of Teclistamab Followed by Autologous Stem Cell Transplant in Functional High-risk and Triple-class Refractory Multiple Myeloma.

Vincenzo Sammartano, Sara Ciofini, Beatrice Esposito Vangone, Chiara Carrara, Monica Bocchia, Alessandro Gozzetti

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vincenzo SammartanoHematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy.
Sara CiofiniHematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy.
Beatrice Esposito VangoneHematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy.
Chiara CarraraHematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy.
Monica BocchiaHematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy.
Alessandro GozzettiHematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Autologous stem cell transplantRefractory multiple myelomaTeclistamab

Identifiers

PMID40636280
PMCPMC12240253

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.